ACIU Reports $74.8M Cash, $12M Takeda Milestone, $10M Lilly Upfront, AD4 Initiated, AD3 Interim Q2, ACI-19764 Phase 1 Started, Morphomer-Tau Amended, AD/PD 2026 Data
AC Immune SA · Now $2.46
-6.6% in 7d after detection
Post-detection moves
1h
—
1d
-1.7%
3d
-0.7%
7d
-6.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS